4-Hydroxythiobenzamide (4-HTBA) is used mainly as a key intermediate in pharmaceutical synthesis, notably in making Febuxostat (for gout), PPARα agonists (for cholesterol management), and CDK5 inhibitors (for Alzheimer’s disease), acting as a crucial building block to create complex drug molecules for various conditions, including cardiovascular and neurodegenerative diseases.
4-Hydroxythiobenzamide
| API Name | Febuxostat |
|---|---|
| CAS No | 25984-63-8 |
| Molecular Formula | C7H7NOS |
| Molecular Weight | 153.20 g/mol |
| Synonyms | 4-hydroxybenzenecarbothioamide |
Zoho Contact Form
"*" indicates required fields